UK markets closed

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.1900-0.0600 (-2.67%)
At close: 04:00PM EDT
2.2000 +0.01 (+0.46%)
After hours: 07:36PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1122
Avg. Estimate-0.79-0.37-1.77-1.49
Low estimate-0.79-0.37-1.83-1.52
High estimate-0.79-0.37-1.71-1.46
Year ago EPS-0.96-1.11-3.57-1.77
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/A260kN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.87-0.92-1.12-0.85
Actual EPS-0.96-1.11-0.86-0.64
Difference-0.09-0.190.260.21
Surprise %-10.30%-20.70%23.20%24.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.79-0.37-1.77-1.49
7 days ago-0.79-0.37-1.77-1.49
30 days ago-0.79-0.37-1.77-1.49
60 days ago-0.79-0.37-1.71-1.52
90 days ago00-4.33-3.99
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIKTIndustrySector(s)S&P 500
Current qtr.17.70%N/AN/AN/A
Next qtr.66.70%N/AN/AN/A
Current year50.40%N/AN/AN/A
Next year15.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A